
|Videos|June 14, 2016
Use of Liquid Biopsies for Patients With EGFR-Mutated NSCLC
Author(s)Heather A. Wakelee, MD
Heather A. Wakelee, MD, discusses a study utilizing liquid biopsies in patients with non-small cell lung cancer who harbor EGFR mutations.
Advertisement
Heather A. Wakelee, MD, associate professor of Medicine (Oncology), Stanford University Medical Center, discusses a study utilizing liquid biopsies in patients with nonsmall cell lung cancer who harborEGFR
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
4
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
5









































